Matches in SemOpenAlex for { <https://semopenalex.org/work/W2502300311> ?p ?o ?g. }
- W2502300311 endingPage "5466" @default.
- W2502300311 startingPage "5455" @default.
- W2502300311 abstract "Aberrant cell-cycle progression is a hallmark feature of cancer cells. Cyclin-dependent kinases 4 and 6 (CDK4/6) drive progression through the G1 stage of the cell cycle, at least in part, by inactivating the tumor suppressor, retinoblastoma. CDK4/6 are targetable and the selective CDK4/6 inhibitor, palbociclib, was recently FDA approved for the treatment of estrogen receptor-positive, HER2-negative advanced breast cancer. In cutaneous melanoma, driver mutations in NRAS and BRAF promote CDK4/6 activation, suggesting that inhibitors such as palbociclib are likely to provide therapeutic benefit in combination with BRAF inhibitors and/or MEK inhibitors that are FDA-approved. However, the determinants of the response to CDK4/6 inhibitors alone and in combination with other targeted inhibitors are poorly defined. Furthermore, in vivo systems to quantitatively and temporally measure the efficacy of CDK4/6 inhibitors and determine the extent that CDK activity is reactivated during acquired resistance are lacking. Here, we describe the heterogeneous effects of CDK4/6 inhibitors, the expression of antiapoptotic proteins that associate with response to CDK4/6 and MEK inhibitors, and the development of a luciferase-based reporter system to determine the effects of CDK4/6 inhibitors alone and in combination with MEK inhibitors in melanoma xenografts. These findings are likely to inform on-going and future clinical trials utilizing CDK4/6 inhibitors in cutaneous melanoma. Cancer Res; 76(18); 5455-66. ©2016 AACR." @default.
- W2502300311 created "2016-08-23" @default.
- W2502300311 creator A5016616108 @default.
- W2502300311 creator A5022471130 @default.
- W2502300311 creator A5029143392 @default.
- W2502300311 creator A5047768044 @default.
- W2502300311 creator A5048327749 @default.
- W2502300311 creator A5057893861 @default.
- W2502300311 creator A5085398803 @default.
- W2502300311 date "2016-09-15" @default.
- W2502300311 modified "2023-10-04" @default.
- W2502300311 title "An <i>In Vivo</i> Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma" @default.
- W2502300311 cites W1464936406 @default.
- W2502300311 cites W1964638367 @default.
- W2502300311 cites W1965370740 @default.
- W2502300311 cites W1967902354 @default.
- W2502300311 cites W1984245506 @default.
- W2502300311 cites W1985850253 @default.
- W2502300311 cites W1991601194 @default.
- W2502300311 cites W2000123112 @default.
- W2502300311 cites W2002034430 @default.
- W2502300311 cites W2011261819 @default.
- W2502300311 cites W2044348066 @default.
- W2502300311 cites W2050130956 @default.
- W2502300311 cites W2058390096 @default.
- W2502300311 cites W2058570034 @default.
- W2502300311 cites W2077945404 @default.
- W2502300311 cites W2085484189 @default.
- W2502300311 cites W2096387850 @default.
- W2502300311 cites W2109387929 @default.
- W2502300311 cites W2116978375 @default.
- W2502300311 cites W2117692326 @default.
- W2502300311 cites W2126983941 @default.
- W2502300311 cites W2132141505 @default.
- W2502300311 cites W2143163879 @default.
- W2502300311 cites W2144790402 @default.
- W2502300311 cites W2145657367 @default.
- W2502300311 cites W2148345265 @default.
- W2502300311 cites W2156078931 @default.
- W2502300311 cites W2163755403 @default.
- W2502300311 cites W2165656117 @default.
- W2502300311 cites W2166229764 @default.
- W2502300311 cites W2168143310 @default.
- W2502300311 cites W2171367970 @default.
- W2502300311 cites W2572174216 @default.
- W2502300311 doi "https://doi.org/10.1158/0008-5472.can-15-3384" @default.
- W2502300311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5026598" @default.
- W2502300311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27488531" @default.
- W2502300311 hasPublicationYear "2016" @default.
- W2502300311 type Work @default.
- W2502300311 sameAs 2502300311 @default.
- W2502300311 citedByCount "23" @default.
- W2502300311 countsByYear W25023003112017 @default.
- W2502300311 countsByYear W25023003112018 @default.
- W2502300311 countsByYear W25023003112019 @default.
- W2502300311 countsByYear W25023003112020 @default.
- W2502300311 countsByYear W25023003112021 @default.
- W2502300311 countsByYear W25023003112022 @default.
- W2502300311 crossrefType "journal-article" @default.
- W2502300311 hasAuthorship W2502300311A5016616108 @default.
- W2502300311 hasAuthorship W2502300311A5022471130 @default.
- W2502300311 hasAuthorship W2502300311A5029143392 @default.
- W2502300311 hasAuthorship W2502300311A5047768044 @default.
- W2502300311 hasAuthorship W2502300311A5048327749 @default.
- W2502300311 hasAuthorship W2502300311A5057893861 @default.
- W2502300311 hasAuthorship W2502300311A5085398803 @default.
- W2502300311 hasBestOaLocation W25023003111 @default.
- W2502300311 hasConcept C121608353 @default.
- W2502300311 hasConcept C124320809 @default.
- W2502300311 hasConcept C126322002 @default.
- W2502300311 hasConcept C150903083 @default.
- W2502300311 hasConcept C184235292 @default.
- W2502300311 hasConcept C207001950 @default.
- W2502300311 hasConcept C21790070 @default.
- W2502300311 hasConcept C2775930923 @default.
- W2502300311 hasConcept C2776062698 @default.
- W2502300311 hasConcept C2777658100 @default.
- W2502300311 hasConcept C2778298596 @default.
- W2502300311 hasConcept C2779744173 @default.
- W2502300311 hasConcept C2781187634 @default.
- W2502300311 hasConcept C2781249067 @default.
- W2502300311 hasConcept C29537977 @default.
- W2502300311 hasConcept C502942594 @default.
- W2502300311 hasConcept C51853150 @default.
- W2502300311 hasConcept C526805850 @default.
- W2502300311 hasConcept C530470458 @default.
- W2502300311 hasConcept C57074206 @default.
- W2502300311 hasConcept C71924100 @default.
- W2502300311 hasConcept C82495950 @default.
- W2502300311 hasConcept C86803240 @default.
- W2502300311 hasConcept C95444343 @default.
- W2502300311 hasConcept C98274493 @default.
- W2502300311 hasConceptScore W2502300311C121608353 @default.
- W2502300311 hasConceptScore W2502300311C124320809 @default.
- W2502300311 hasConceptScore W2502300311C126322002 @default.
- W2502300311 hasConceptScore W2502300311C150903083 @default.
- W2502300311 hasConceptScore W2502300311C184235292 @default.
- W2502300311 hasConceptScore W2502300311C207001950 @default.